Changes in the local tumor microenvironment in recurrent cancers may explain the failure of vaccines after surgery

Vascular Endothelial-Targeted Therapy Combined with Cytotoxic Chemotherapy Induces Inflammatory Intratumoral Infiltrates and Inhibits Tumor Relapses after Surgery

(2015) Brendan F. Judy et al.   NEOPLASIA

A positive-margin resection model recreates the postsurgical tumor microenvironment and is a reliable model for adjuvant therapy evaluation

(2012) Jarrod D. Predina et al.   CANCER BIOLOGY & THERAPY

Adjuvant immunotherapy for non-small cell lung cancer

(2012) Zachary C.G. Tucker et al.   CANCER TREATMENT REVIEWS

Cytoreduction surgery reduces systemic myeloid suppressor cell populations and restores intratumoral immunotherapy effectiveness

(2012) Jarrod D Predina et al.   Journal of Hematology & Oncology

Neoadjuvant in situ gene-mediated cytotoxic immunotherapy improves postoperative outcomes in novel syngeneic esophageal carcinoma models

(2011) J D Predina et al.   CANCER GENE THERAPY

Adjuvant Combination and Antigen Targeting as a Strategy to Induce Polyfunctional and High-Avidity T-Cell Responses against Poorly Immunogenic Tumors

(2011) F. Aranda et al.   CANCER RESEARCH

Differential Response of Human and Mouse Dendritic Cells to VEGF Determines Interspecies Discrepancies in Tumor-Mediated Th1/Th2 Polarity Shift

(2011) M. S. Block et al.   CLINICAL CANCER RESEARCH

A Live-Attenuated Listeria Vaccine (ANZ-100) and a Live-Attenuated Listeria Vaccine Expressing Mesothelin (CRS-207) for Advanced Cancers: Phase I Studies of Safety and Immune Induction

(2011) D. T. Le et al.   CLINICAL CANCER RESEARCH

Local and Systemic Recurrence is the Achilles Heel of Cancer Surgery

(2010) Louis A. Aliperti et al.   ANNALS OF SURGICAL ONCOLOGY

Cancer Statistics, 2010

(2010) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

A shot in the arm for cancer vaccines?

(2010) Heidi Ledford   NATURE

Neoadjuvant Vaccination Provides Superior Protection against Tumor Relapse following Surgery Compared with Adjuvant Vaccination

(2009) N. Grinshtein et al.   CANCER RESEARCH